Cargando…
Coenzyme Q10 therapy in patients with post COVID-19 condition – Authors’ response
Autores principales: | Hansen, Kristoffer Skaalum, Leth, Steffen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9850419/ https://www.ncbi.nlm.nih.gov/pubmed/36691395 http://dx.doi.org/10.1016/j.lanepe.2022.100571 |
Ejemplares similares
-
Coenzyme Q10 therapy in patients with post COVID-19 condition
por: Kow, Chia Siang, et al.
Publicado: (2023) -
High-dose coenzyme Q10 therapy versus placebo in patients with post COVID-19 condition: a randomized, phase 2, crossover trial
por: Hansen, Kristoffer S., et al.
Publicado: (2022) -
ND2 mutation with minimal coenzyme-Q responsive manifestations()
por: Finsterer, Josef, et al.
Publicado: (2017) -
Atherosclerosis and Coenzyme Q(10)
por: Suárez-Rivero, Juan M., et al.
Publicado: (2019) -
Association between genetic variants in the Coenzyme Q(10 )metabolism and Coenzyme Q(10 )status in humans
por: Fischer, Alexandra, et al.
Publicado: (2011)